Patent 7736672 was granted and assigned to Pfizer Limited on June, 2010 by the United States Patent and Trademark Office.
A process is described for producing drug-containing multiparticulates with improved stability, characterized by an improvement in one or more of chemical stability, physical stability, or dissolution stability.